Latest news with #CoromandelInternational
Mint
4 days ago
- Business
- Mint
Canara Bank to Hero MotoCorp: Eight stocks to buy for up to 15% gains on robust monsoon, strong Indian economy
The Indian stock market benchmark indices, Sensex and Nifty 50, extended rally for the third consecutive month in May. Nifty 50 has gained 1.7% this month, underpinned by easing tariff concerns, positive developments in India–US trade negotiations, and a rebound in Foreign Institutional Investor (FII) inflows The next key trigger for the Indian stock market would be the monsoon season. According to the India Meteorological Department (IMD) India is likely to experience above average monsoon rains in 2025. This projection signals a potentially fruitful agriculture season which is crucial for rural demand and benefit sectors like agrochemicals, fertilizers, tractors, two-wheelers and FMCG. Green shoots of recovery in rural markets, sustained momentum in manufacturing and services sectors augur well for consumption demand in the near term, analysts said. 'Steadily improving macros like resilient GDP growth, down trending inflation and interest rates and declining fiscal and current account deficits lay the foundation for a strong economy and earnings recovery in the medium term. Investors should remain invested and buy quality stocks on dips,' said VK Vijayakumar, Chief Investment Strategist, Geojit Investments. Meanwhile, brokerage firm Way2Wealth has released the list of Monsoon stock picks. The stocks are believed to gain from improving rural liquidity and demand on the back of better monsoon. It believes these quality stocks have strong fundamentals and a positive correlation to monsoon trends and other key macroeconomic indicators. The brokerage firm suggests these stocks to buy for a time horizon of 6-8 months. These stocks to buy include Bayer CropScience, Canara Bank, Coromandel International, Emami, Godrej Agrovet, Hero MotoCorp, Supreme Industries and Swaraj Engines. Here are the Monsoon stock picks by Way2Wealth: Bayer CropScience is expected to maintain a revenue, EBITDA and PAT CAGR of 10%, 30% and 28% over FY25–27E, respectively. At the CMP, Bayer CropScience share price is trading at a P/E of 28x and an EV/EBITDA of 21x based on FY27E estimates, Way2Wealth said. The brokerage firm assigns a 'Buy' rating to Way2Wealth shares with a target price of ₹ 6,450 apiece. Canara Bank's balance sheet stands strong with CRAR at 16.3%. It will be further strengthened with IPO proceeds of Canara Robeco which will provide growth capital to the bank, said the brokerage firm. It has a 'Buy' call on Canara Bank shares with a target price of ₹ 125. Coromandel International is progressing with key projects, targeting commissioning by FY26–27. It is focusing on capex realignment, backward integration, and new product growth such as Nano DAP, while maintaining a revenue, EBITDA and PAT CAGR of 9%, 22% and 17% over FY25-27E, respectively. At the CMP, Coromandel International shares are trading at a P/E of 25x and an EV/EBITDA of 17x based on FY27E estimates. Way2Wealth assigns a 'Buy' rating to Coromandel International shares, with a target price of ₹ 2,700 apiece. Emami remains committed to grow through various initiatives like newer launches, expanded reach and increased digital presence through e-commerce channels despite high inflationary environment and urban slowdown. Further, it has a strong presence in the niche personal care categories, with low penetration. At CMP, Emami stock is trading at 27x its FY26 P/E . The brokerage firm recommends a 'Buy' call on Emami shares based on its strong fundamentals. It has Emami share price target of ₹ 660 apiece. Godrej Agrovet's diversified products across less regulated agricultural inputs and outputs, leading market positions across all of them and high-quality management and parentage, makes it a proxy to ride the theme of Indian agriculture, said the brokerage firm. The company has a strong Balance Sheet and generates healthy cash flows and return ratios. At CMP, Godrej Agrovet stock price is trading at 28x its FY26 P/E. The brokerage has a 'Buy' call on the stock with a target of ₹ 840 level. Way2Wealth remains optimistic about growth of the company in the near term. The company currently trades at a P/E 15.9x on FY27E below its 5-year average P/E of 21.6x. It has a 'Buy' rating and Hero MotoCorp share price target of ₹ 5,000 A recovery in plumbing demand is anticipated as channel inventories stabilize and government spending picks up, the brokerage firm said as it remains optimistic about growth of the company in near term. Supreme Industries shares currently trade at a P/E 39.7x on FY27E below its 5-year Average PE of 42.2x. The brokerage recommends buying Supreme Industries shares for a target price of ₹ 4,750 apiece. The company's engine business is likely to move in tandem with industry. Further, return ratios (RoCE: ~53+%, RoE: ~40%) along with positive FCF generation will also be among the key triggers, said the broking house. At CMP, Swaraj Engines share price is trading at 26x its FY26 P/E. It recommends buying Swaraj Engines shares for a target price of ₹ 4,600 apiece. Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.
Business Standard
6 days ago
- Business
- Business Standard
EID Parry Q4 PAT rises 30% YoY to Rs 287 cr
EID Parry (India) reported a 30.05% jump in consolidated net profit to Rs 286.52 crore on a 22.57% rise in net sales to Rs 6,811.12 crore in Q4 March 2025, compared to the same period last year. Profit before tax (PBT) surged 92.15% YoY to Rs 734.54 crore during the quarter. Earnings before interest, tax, depreciation, and amortization (EBITDA) (excluding exceptional items of Rs 347 crore) for the quarter ended 31 March 2025 was Rs 626 crore, registering an increase of 8% in comparison to the corresponding quarter of the previous year. On the segmental front, the companys revenue from the sugar business stood at Rs 1,372.89 crore (up 6.79% YoY), distillery came in at Rs 268.19 crore (up 19.8% YoY), consumer products stood at Rs 195.32 crore (up 44.79%), crop protection was at Rs 698.72 crore (up 23.8% YoY), and nutrient and allied business was at Rs 4,320.96 crore (up 28.21% YoY) during the period under review. On the other hand, the firms income from nutraceuticals was at Rs 59.31 crore (down 15.32% YoY), and revenue from cogeneration stood at Rs 57.93 crore (down 25.49% YoY) in Q4 FY25. On a standalone basis, EID Parry posted a net loss of Rs 231.70 crore in Q4 FY25, against a net profit of Rs 80.27 crore in Q4 FY24. Standalone net sales rose 13.54% YoY to Rs 813.67 crore. Segment-wise, the farm inputs division continued to lead performance, recording a profit before interest and tax (PBIT) of Rs 398 crore for the quarter, up 26.35% from Rs 315 crore a year ago. In contrast, the sugar division reported a sharp decline in profitability, with PBIT falling to Rs 26 crore from Rs 164 crore in Q4 FY24. The nutraceuticals division posted a modest profit of Rs 11 crore, compared to Rs 16 crore in the same quarter last year. Meanwhile, the consumer products group (CPG) division widened its loss to Rs 13 crore from Rs 4 crore in the corresponding period last year. Meanwhile, the company noted that its subsidiary, Coromandel International, has declared a final dividend of Rs 6 per share and a special dividend of Rs 3 per share. EID Parry is expected to receive a total income of Rs 148.91 crore from this payout. Furthermore, the board has approved an investment of up to Rs 350 crore in Parry Sugars Refinery India (PSRIPL), its wholly owned subsidiary. The investment, to be made in one or more tranches, is intended to support debt reduction and strengthen the subsidiarys net worth. EID Parry (India) is engaged in sugar, nutraceuticals, and ethanol production. It also has a significant presence in the farm inputs business, including biopesticides, through its subsidiary, Coromandel International. Shares of EID Parry (India) rose 0.95% to Rs 990.45 on the BSE.
Business Standard
20-05-2025
- Business
- Business Standard
Coromandel International allots 2.01 lakh equity shares under ESOP
Coromandel International has allotted 2,01,610 equity shares under ESOP on 20 May 2025. With this allotment, the share capital of the Company shall stand increased from Rs. 29,46,36,339/- divided into 29,46,36,339 equity shares of face value Re. 1/- each to Rs. 29,48,37,949/- divided into 29,48,37,949 equity shares of face value Re. 1/- each.
Time of India
15-05-2025
- Business
- Time of India
MSCI adds Coromandel International and Nykaa to Global Standard Index
Synopsis MSCI has included Coromandel International and Nykaa in its Global Standard Index, effective May 30, potentially triggering $408 million in passive fund flows. Simultaneously, 22 stocks were removed and 11 added to the India Small Cap Index, marking a significant shift. Cipla, Indus Towers, and Grasim Industries will see increased weightage, while Astral's weightage will decrease.
Time of India
14-05-2025
- Business
- Time of India
Nykaa, Coromandel International to join MSCI India Index in May review
NEW DELHI: Beauty and fashion retailer Nykaa and fertilizer maker Coromandel International are set to be included in the MSCI India Index , according to the latest review by global index provider MSCI. The changes to the MSCI Global Standard Indexes will take effect from May 30, 2025, as stated in MSCI's announcement. FSN E-Commerce Ventures ' shares registered a 3.44% increase on the BSE. Coromandel International's stock rose by 1.82% but later gave up all gains to end nearly 4% lower. MSCI, serves as a primary provider of essential decision support instruments and services for international investors. It has announced that in the MSCI Global Smallcap Indexes, 11 firms will be added, while 22 companies will move out effective May 30. The new additions comprise AWL Agri Business, ACME Solar Holdings, Authum Investment, Dr Agarwals Health Care, Godrej Agrovet, Hexaware Technologies, International Gemmological, Le Travenues Technology, Sagility India, Sai Life Sciences and Tata Technologies. The companies set for removal include Aarti Drugs, Allcargo Logistics, Coromandel International, E2E Networks, Electronics Mart India, Gateway Distriparks, Godrej Industries, Greenpanel Industries, Gujarat Alkalies, HeidelbergCement, Hemisphere Properties, Moschip Technologies, NOCIL, Orchid Pharma, Orissa Minerals Development Company, Paisalo Digital, Patel Engineering, Prince Pipes and Fittings, Rossari Biotech, Share India Securities, Shyam Metalics and TeamLease Services. Stay informed with the latest business news, updates on bank holidays and public holidays . AI Masterclass for Students. Upskill Young Ones Today!– Join Now
